The early concern that GLP-1 causes thyroid cancer has lead to extensive investigations and studies looking at this issues and to date there has been nothing to suggest a concern despite millions of people being treated with GLP-1 therapies around the world
Transitioning from Semaglutide to Tirzepatide Some patients may consider switching from Semaglutide to Tirzepatide for various reasons
Editorial refresh Practical 2026 note for Retatrutide vs CagriSema vs Survodutide For this provider comparisons page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, cagrisema, survodutide so the article stays close to the question behind "Retatrutide vs CagriSema vs Survodutide"
Each outcome was separately analyzed
People on Medicaid typically do not pay a copay
Additionally, certain medicationsincluding some antidepressants, antipsychotics, and corticosteroidscan increase appetite and potentially counteract semaglutide's effects